HilleVax, Inc (HLVX)
US Market

HilleVax, Inc (HLVX) Income Statement


HilleVax, Inc Income Statement

Last quarter (Q1 2024), HilleVax, Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, HilleVax, Inc's net income was $-46.83M. See HilleVax, Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
---$ 0.00$ 0.00
Cost of Revenue
$ 168.00K-$ -2.43M--
Gross Profit
$ -168.00K-$ 2.43M--
Operating Expense
$ 154.18M$ 133.34M$ -65.11M$ 15.77M$ 1.29M
Operating Income
$ -154.18M$ -133.34M$ -65.11M$ -15.77M$ -1.29M
Net Non Operating Interest Income Expense
$ 6.86M$ 7.31M$ -51.01M$ -2.84M$ -29.00K
Other Income Expense
$ -3.69M$ -2.46M$ 43.69M$ -83.79M$ -779.00K
Pretax Income
$ 111.04M$ 89.79M$ -159.81M$ -102.41M$ -2.10M
Tax Provision
$ -1.29M$ -1.29M$ 1.37M--
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -88.92M$ -123.57M$ -159.81M$ -53.45M$ -2.10M
Basic EPS
$ -3.30$ -3.04$ -5.89$ -3.28$ -0.13
Diluted EPS
$ -3.30$ -3.04$ -5.89$ -3.28$ -0.13
Basic Average Shares
$ 173.10M$ 40.60M$ 27.15M$ 16.29M$ 16.29M
Diluted Average Shares
$ 173.10M$ 40.60M$ 27.15M$ 16.29M$ 16.29M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 154.35M$ 133.34M$ -67.54M$ 15.77M$ 1.29M
Net Income From Continuing And Discontinued Operation
$ -143.51M$ -123.57M$ -159.81M$ -102.41M$ -2.10M
Normalized Income
$ 107.48M$ 89.05M-$ -38.84M$ -2.10M
Interest Expense
---$ 2.84M$ 29.00K
$ -40.38M$ 92.19M$ -156.40M$ -99.56M$ -2.07M
$ -61.90M$ 92.01M$ -156.10M$ -99.56M$ -2.07M
Currency in USD

HilleVax, Inc Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis